Gerald Mboowa

About

Gerald Mboowa is a scientist committed to advancing the integration and application of genome sequencing technologies to address critical challenges in health and disease. His work spans outbreak investigation, pathogen characterization, and antimicrobial resistance (AMR) surveillance, employing cutting-edge sequencing and bioinformatics tools. In AMR research, Gerald focuses on uncovering the genomic determinants of resistance and virulence, elucidating the mechanisms underlying these traits to inform better diagnostics, treatments, and policies.

By leveraging data science, genomics, and bioinformatics, his research contributes to improving our understanding of complex biological systems and translating genomic insights into actionable strategies for enhancing global health outcomes.

Employment

• Africa Centres for Disease Control and Prevention
  2021 - 2024
• Infectious Diseases Institute HIV Co-Infections in Uganda Fogarty Postdoctoral fellow
  2020 - 2021
• The African Center of Excellence in Bioinformatics & Data-Intensive Sciences, Infectious Diseases Institute, McKinnell Knowledge Centre, Makerere University Senior Scientist
  2019 - Present
• Makerere University College of Health Sciences
  2009 - 2019

Education

• University of Cambridge Fellow
  2018 - 2018
• Makerere University Ph.D
  2015 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (152)

• Uganda’s Mandatory Newborn Sickle Cell Disease Screening Programme: Translating a Decade of Evidence into Differentiated Implementation
  Pediatric Health, Medicine and Therapeutics 2026 DOI: 10.2147/PHMT.S621156
  +Save
• Genomic characterization of two Staphylococcus aureus isolates from a Tanzanian orthopaedics ward: a fomite-associated ST152 MSSA isolate and a rectal-swab ST8 mecA-positive isolate
  BMC Genomic Data 2026 DOI: 10.1186/s12863-026-01480-0
  +Save
• Predicting treatment-emergent antimicrobial resistance at the patient level in LMICs
  Zenodo 2026 DOI: 10.5281/zenodo.21456235
  +Save
• Genomic characterization of ESBL-producing Escherichia coli isolates from patients in an orthopaedic ward in Mwanza, Tanzania [version 2; peer review: 1 approved, 1 approved with reservations, 1 not approved]
  2026 DOI: 10.12688/f1000research.180294.2
  +Save
• Genomic characterization of ESBL-producing Escherichia coli isolates from patients in an orthopaedic ward in Mwanza, Tanzania
  F1000Research 2026 DOI: 10.12688/f1000research.180294.1
  +Save
• Conserved neutrophil degranulation transcripts in HIV-TB coinfected children across East and Southern Africa
  Communications Medicine 2026 DOI: 10.1038/s43856-025-01284-w
  +Save
• Multicountry genomic analysis underscores regional cholera spread in Africa
  Nature Communications 2026 DOI: 10.1038/s41467-026-68642-7
  +Save
• Pathways, outputs and impact of NIH-supported bioinformatics and genomics graduate trainees in Africa
  Briefings in Bioinformatics 2026 DOI: 10.1093/bib/bbag046
  +Save
• rMAP 2.0: a modular, reproducible, and scalable WDL–Cromwell–Docker workflow for genomic analysis of ESKAPEE pathogens
  Bioinformatics Advances 2026 DOI: 10.1093/bioadv/vbag046
  +Save
• ESKAPEE BLAST nucleotide database (rMAP-2.0)
  Zenodo 2025 DOI: 10.5281/zenodo.18001237
  +Save